Literature DB >> 26289642

The forkhead transcription factor FOXP1 represses human plasma cell differentiation.

Martine van Keimpema1, Leonie J Grüneberg1, Michal Mokry2, Ruben van Boxtel3, Menno C van Zelm4, Paul Coffer5, Steven T Pals1, Marcel Spaargaren1.   

Abstract

Expression of the forkhead transcription factor FOXP1 is essential for early B-cell development, whereas downregulation of FOXP1 at the germinal center (GC) stage is required for GC B-cell function. Aberrantly high FOXP1 expression is frequently observed in diffuse large B-cell lymphoma and mucosa-associated lymphoid tissue lymphoma, being associated with poor prognosis. Here, by gene expression analysis upon ectopic overexpression of FOXP1 in primary human memory B cells (MBCs) and B-cell lines, combined with chromatin immunoprecipitation and sequencing, we established that FOXP1 directly represses expression of PRDM1, IRF4, and XBP1, transcriptional master regulators of plasma cell (PC) differentiation. In accordance, FOXP1 is prominently expressed in primary human naive and MBCs, but expression strongly decreases during PC differentiation. Moreover, as compared with immunoglobulin (Ig) M(+) MBCs, IgG(+) MBCs combine lower expression of FOXP1 with an enhanced intrinsic PC differentiation propensity, and constitutive (over)expression of FOXP1 in B-cell lines and primary human MBCs represses their ability to differentiate into PCs. Taken together, our data indicate that proper control of FOXP1 expression plays a critical role in PC differentiation, whereas aberrant expression of FOXP1 might contribute to lymphomagenesis by blocking this terminal B-cell differentiation.
© 2015 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26289642      PMCID: PMC4626252          DOI: 10.1182/blood-2015-02-626176

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  56 in total

1.  Gene expression profiling of B lymphocytes and plasma cells from Waldenström's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals.

Authors:  N C Gutiérrez; E M Ocio; J de Las Rivas; P Maiso; M Delgado; E Fermiñán; M J Arcos; M L Sánchez; J M Hernández; J F San Miguel
Journal:  Leukemia       Date:  2007-01-25       Impact factor: 11.528

2.  Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma.

Authors:  J Iqbal; T C Greiner; K Patel; B J Dave; L Smith; J Ji; G Wright; W G Sanger; D L Pickering; S Jain; D E Horsman; Y Shen; K Fu; D D Weisenburger; C P Hans; E Campo; R D Gascoyne; A Rosenwald; E S Jaffe; J Delabie; L Rimsza; G Ott; H K Müller-Hermelink; J M Connors; J M Vose; T McKeithan; L M Staudt; W C Chan
Journal:  Leukemia       Date:  2007-07-12       Impact factor: 11.528

3.  Spi-B inhibits human plasma cell differentiation by repressing BLIMP1 and XBP-1 expression.

Authors:  Heike Schmidlin; Sean A Diehl; Maho Nagasawa; Ferenc A Scheeren; Remko Schotte; Christel H Uittenbogaart; Hergen Spits; Bianca Blom
Journal:  Blood       Date:  2008-06-13       Impact factor: 22.113

4.  Recruitment of the cytoplasmic adaptor Grb2 to surface IgG and IgE provides antigen receptor-intrinsic costimulation to class-switched B cells.

Authors:  Niklas Engels; Lars Morten König; Christina Heemann; Johannes Lutz; Takeshi Tsubata; Sebastian Griep; Verena Schrader; Jürgen Wienands
Journal:  Nat Immunol       Date:  2009-08-09       Impact factor: 25.606

5.  Multiple layers of B cell memory with different effector functions.

Authors:  Ismail Dogan; Barbara Bertocci; Valérie Vilmont; Frédéric Delbos; Jérome Mégret; Sébastien Storck; Claude-Agnès Reynaud; Jean-Claude Weill
Journal:  Nat Immunol       Date:  2009-10-25       Impact factor: 25.606

6.  Downregulation of FOXP1 is required during germinal center B-cell function.

Authors:  Ainara Sagardoy; Jose I Martinez-Ferrandis; Sergio Roa; Karen L Bunting; María Angela Aznar; Olivier Elemento; Rita Shaknovich; Lorena Fontán; Vicente Fresquet; Ignacio Perez-Roger; Eloy F Robles; Linde De Smedt; Xavier Sagaert; Ari Melnick; Jose A Martinez-Climent
Journal:  Blood       Date:  2013-04-11       Impact factor: 22.113

7.  Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways.

Authors:  Georg Lenz; George W Wright; N C Tolga Emre; Holger Kohlhammer; Sandeep S Dave; R Eric Davis; Shannon Carty; Lloyd T Lam; A L Shaffer; Wenming Xiao; John Powell; Andreas Rosenwald; German Ott; Hans Konrad Muller-Hermelink; Randy D Gascoyne; Joseph M Connors; Elias Campo; Elaine S Jaffe; Jan Delabie; Erlend B Smeland; Lisa M Rimsza; Richard I Fisher; Dennis D Weisenburger; Wing C Chan; Louis M Staudt
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-02       Impact factor: 11.205

8.  Molecular footprints of a germinal center derivation of human IgM+(IgD+)CD27+ B cells and the dynamics of memory B cell generation.

Authors:  Marc Seifert; Ralf Küppers
Journal:  J Exp Med       Date:  2009-11-16       Impact factor: 14.307

9.  Enhancement and suppression of signaling by the conserved tail of IgG memory-type B cell antigen receptors.

Authors:  Keisuke Horikawa; Stephen W Martin; Sarah L Pogue; Karlee Silver; Kaiman Peng; Kiyoshi Takatsu; Christopher C Goodnow
Journal:  J Exp Med       Date:  2007-04-09       Impact factor: 14.307

10.  Germinal centers in human lymph nodes contain reactivated memory B cells.

Authors:  Richard J Bende; Febe van Maldegem; Martijn Triesscheijn; Thera A M Wormhoudt; Richard Guijt; Carel J M van Noesel
Journal:  J Exp Med       Date:  2007-10-15       Impact factor: 14.307

View more
  21 in total

1.  Rituximab-resistant splenic memory B cells and newly engaged naive B cells fuel relapses in patients with immune thrombocytopenia.

Authors:  Etienne Crickx; Pascal Chappert; Aurélien Sokal; Sandra Weller; Imane Azzaoui; Alexis Vandenberghe; Guillaume Bonnard; Geoffrey Rossi; Tatiana Fadeev; Sébastien Storck; Jehane Fadlallah; Véronique Meignin; Etienne Rivière; Sylvain Audia; Bertrand Godeau; Marc Michel; Jean-Claude Weill; Claude-Agnès Reynaud; Matthieu Mahévas
Journal:  Sci Transl Med       Date:  2021-04-14       Impact factor: 17.956

2.  Spec-seq unveils transcriptional subpopulations of antibody-secreting cells following influenza vaccination.

Authors:  Karlynn E Neu; Jenna J Guthmiller; Min Huang; Jennifer La; Marcos C Vieira; Kangchon Kim; Nai-Ying Zheng; Mario Cortese; Micah E Tepora; Natalie J Hamel; Karla Thatcher Rojas; Carole Henry; Dustin Shaw; Charles L Dulberger; Bali Pulendran; Sarah Cobey; Aly A Khan; Patrick C Wilson
Journal:  J Clin Invest       Date:  2018-11-19       Impact factor: 14.808

3.  PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomas.

Authors:  Marién Pascual; María Mena-Varas; Eloy Francisco Robles; Maria-Jose Garcia-Barchino; Carlos Panizo; Sandra Hervas-Stubbs; Diego Alignani; Ainara Sagardoy; Jose Ignacio Martinez-Ferrandis; Karen L Bunting; Stephen Meier; Xavier Sagaert; Davide Bagnara; Elizabeth Guruceaga; Oscar Blanco; Jon Celay; Alvaro Martínez-Baztan; Noelia Casares; Juan José Lasarte; Thomas MacCarthy; Ari Melnick; Jose Angel Martinez-Climent; Sergio Roa
Journal:  Blood       Date:  2019-04-11       Impact factor: 22.113

4.  Subtype-specific addiction of the activated B-cell subset of diffuse large B-cell lymphoma to FOXP1.

Authors:  Joseph D Dekker; Daechan Park; Arthur L Shaffer; Holger Kohlhammer; Wei Deng; Bum-Kyu Lee; Gregory C Ippolito; George Georgiou; Vishwanath R Iyer; Louis M Staudt; Haley O Tucker
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-19       Impact factor: 11.205

5.  PUMILIO/FOXP1 signaling drives expansion of hematopoietic stem/progenitor and leukemia cells.

Authors:  Cécile Naudin; Aurore Hattabi; Fabio Michelet; Ayda Miri-Nezhad; Aissa Benyoucef; Françoise Pflumio; François Guillonneau; Serge Fichelson; Isabelle Vigon; Isabelle Dusanter-Fourt; Evelyne Lauret
Journal:  Blood       Date:  2017-02-23       Impact factor: 22.113

Review 6.  Forkhead box transcription factors as context-dependent regulators of lymphocyte homeostasis.

Authors:  Dietmar M W Zaiss; Paul J Coffer
Journal:  Nat Rev Immunol       Date:  2018-11       Impact factor: 53.106

7.  High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine.

Authors:  Daniel O'Connor; Elizabeth A Clutterbuck; Amber J Thompson; Matthew D Snape; Maheshi N Ramasamy; Dominic F Kelly; Andrew J Pollard
Journal:  Genome Med       Date:  2017-01-30       Impact factor: 11.117

8.  Autoimmunity as a Driving Force of Cognitive Evolution.

Authors:  Serge Nataf
Journal:  Front Neurosci       Date:  2017-10-26       Impact factor: 4.677

9.  IL-2 imprints human naive B cell fate towards plasma cell through ERK/ELK1-mediated BACH2 repression.

Authors:  Nicolas Hipp; Hannah Symington; Cédric Pastoret; Gersende Caron; Céline Monvoisin; Karin Tarte; Thierry Fest; Céline Delaloy
Journal:  Nat Commun       Date:  2017-11-13       Impact factor: 14.919

10.  FOXP2-positive diffuse large B-cell lymphomas exhibit a poor response to R-CHOP therapy and distinct biological signatures.

Authors:  Kah Keng Wong; Duncan M Gascoyne; Elizabeth J Soilleux; Linden Lyne; Hayley Spearman; Giovanna Roncador; Lars M Pedersen; Michael B Møller; Tina M Green; Alison H Banham
Journal:  Oncotarget       Date:  2016-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.